UT Arlington Researchers Advance Alzheimer's Understanding with Breakthrough in Identifying Various Forms of Amyloid Beta

Daniel Armstrong, PhD, MS

Researchers at The University of Texas at Arlington make significant strides in Alzheimer's research, developing pioneering methods to identify and characterize diverse irregular forms of amyloid beta. This breakthrough offers valuable insights into the elusive causes of Alzheimer's, crucial for the development of medications and immunotherapies. Daniel W. Armstrong, the lead author and Welch Distinguished Professor of Chemistry and Biochemistry, underscores the significance of this research in potentially advancing efforts to halt the progression of Alzheimer's disease.

Previous
Previous

UT Dallas Researcher Secures Grant to Explore Brain Stimulation for Cognitive Issues in Multiple Sclerosis Patients

Next
Next

TCU Students Harness Design Thinking to Innovate Solutions for Healthcare Challenges